WithdrawnNot Applicable

HMP for Addictions Study

Stopped: prioritizing other opportunities

0Started 2025-05

Plain-language summary

The goal of this clinical trial is to see whether the Healthy Minds Program for Addictions could be used to help veterans with moderate-severe opioid use disorder and post-traumatic stress disorder stay on buprenorphine maintenance treatment. Participants will be asked to complete a six-week program consisting of 6 weekly, 2-hour in-person group sessions, as well as assessments before the start of the sessions.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Individuals at least 18 years of age * English-speaking * Veterans * Ability to understand and willingness to sign a written informed consent document * Have access to a smartphone, tablet, or computer with internet connection to access recordings for home practice * Ability and willingness to attend all 6 session of the study, and to complete all assessment questionnaires * Verified Post-Traumatic Stress Disorder (PTSD) according to DSM-5 criteria * On buprenorphine maintenance treatment for Opioid use disorder (OUD) for a minimum of 3 months Exclusion Criteria: * Regular daily meditation practice for past 6 months or regular weekly meditation practice for past 12 months * Attended a meditation retreat or a yoga/body practice retreat with a significant meditation component * Previous use of Healthy Minds Program app * Current suicidal intent and/or high self-injury risk, as determined from the interview * Current psychopathology that interferes with study participation as assessed by interview

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Retention in treatment

Timeframe: Through study completion, up to 4 months

Change in predictors of relapse and recovery

Timeframe: Baseline, 3 weeks, 6 weeks

Trial details

NCT IDNCT06063499

SponsorUniversity of Wisconsin, Madison

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08

View on ClinicalTrials.gov More Opioid Use Disorder trials